生物膜
微生物学
抗生素
抗生素耐药性
细菌
体内
巨噬细胞极化
化学
巨噬细胞
生物
体外
生物化学
生物技术
遗传学
作者
Xufeng Zhu,Jiaqi Guo,Yonglan Yang,Jie Liu
出处
期刊:Small
[Wiley]
日期:2023-01-01
卷期号:19 (11): e2204928-e2204928
被引量:35
标识
DOI:10.1002/smll.202204928
摘要
Abstract Inherited bacterial resistance and biofilm‐induced local immune inactivation are important factors in the failure of antibiotics to fight against bacterial infections. Herein, antibiotic‐loaded mesoporous nanozymes (HA@MRuO 2 ‐Cip/GOx) are fabricated for overcoming bacterial resistance, and activating the local immunosuppression in biofilm microenvironment (BME). HA@MRuO 2 ‐Cip/GOx are prepared by physical adsorption between ciprofloxacin (Cip) or glucose oxidase (GOx) and MRuO 2 NPs, and modified with hyaluronic acid (HA). In vitro, HA@MRuO 2 ‐Cip/GOx cleaves extracellular DNA (eDNA) to disrupt biofilm, thereby enhancing Cip kill planktonic bacteria. Furthermore, HA@MRuO 2 ‐Cip/GOx can induce polarization and enhance phagocytosis of a macrophage‐derived cell line. More importantly, in vivo therapeutic performance confirms that HA@MRuO 2 ‐Cip/GOx can trigger macrophage‐related immunity, and effectively alleviate MRSA‐bacterial lung infections. Accordingly, nanocatalytic therapy combined with targeted delivery of antibiotics could enhance the treatment of bacterial infections.
科研通智能强力驱动
Strongly Powered by AbleSci AI